Hot Features
プレミアム
Scholar Rock Holdings Corporation (SRRK)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-04-23 | Ms. Kristina M. BurowIndependent Director | 89.80k | 820.32k | Derivative Exercise and Retained Stock | 4.75 - 26.78 | 103.24k | 668.20% |
| 2026-04-16 | Mr. Robert Keith WoodsCOO | -10.22k | 506.65k | 売り | 49.57 | 48.03k | -17.54% |
| 2026-04-16 | Dr. Akshay Krishnadas VaishnawPresident of R&D, Member of Scientific Advisory Board and Director | -12.25k | 607.09k | 売り | 49.57 | 58.52k | -17.30% |
| 2026-04-16 | Mr. Vikas SinhaCFO & Treasurer | -10.41k | 516.07k | 売り | 49.57 | 47.84k | -17.87% |
| 2026-04-16 | Mr. David L. HallalCEO & Chairman of the Board | -30.62k | 1.52M | 売り | 49.57 | 403.53k | -7.05% |
| 2026-02-23 | Mr. Mo QatananiChief Scientific Officer | -8.48k | 399.35k | Automatic Disposition | 46.94 - 48.48 | 0.00 | -100.00% |
| 2026-02-17 | Mr. Mo QatananiChief Scientific Officer | -7.99k | 371.71k | 売り | 46.53 | 8.48k | -48.50% |
| 2026-02-17 | Ms. Caryn ParlavecchioChief HR Officer | -9.04k | 420.38k | 売り | 46.53 | 86.86k | -9.42% |
| 2026-02-17 | Ms. Junlin HoGeneral Counsel & Corporate Secretary | -9.58k | 445.74k | 売り | 46.53 | 131.65k | -6.78% |
| 2026-02-17 | Dr. Jing L. MarantzChief Medical Officer | -4.16k | 193.42k | 売り | 46.53 | 29.39k | -12.39% |
| 2025-12-11 | Artal Group S.A.法人 | 1.58M | 11.58M | Derivative Exercise and Retained Stock | 7.35 | 10.83M | 17.03% |
| 2026-01-22 | Mr. Mo QatananiChief Scientific Officer | -14.90k | 695.94k | Automatic Disposition | 45.87 - 46.85 | 85.66k | -14.82% |
| 2026-01-16 | Mr. Mo QatananiChief Scientific Officer | -8.41k | 373.88k | 売り | 44.48 | 100.56k | -7.71% |
| 2026-01-16 | Dr. Jing L. MarantzChief Medical Officer | -5.80k | 257.88k | 売り | 44.48 | 24.97k | -18.84% |
| 2026-01-16 | Ms. Caryn ParlavecchioChief HR Officer | -6.60k | 293.55k | 売り | 44.48 | 78.28k | -7.78% |
| 2026-01-16 | Ms. Junlin HoGeneral Counsel & Corporate Secretary | -8.02k | 356.53k | 売り | 44.48 | 121.47k | -6.19% |
| 2026-01-14 | Mr. Mo QatananiChief Scientific Officer | -13.11k | 349.65k | Derivative Exercise and Sale | 7.62 - 45.20 | 108.96k | - |
| 2026-01-13 | Mr. Vikas SinhaCFO & Treasurer | -16.76k | 715.44k | 売り | 42.70 | 33.25k | -33.51% |
| 2026-01-13 | Mr. Robert Keith WoodsCOO | -16.75k | 715.05k | 売り | 42.70 | 33.25k | -33.49% |
| 2026-01-13 | Dr. Akshay Krishnadas VaishnawPresident of R&D, Member of Scientific Advisory Board and Director | -20.44k | 872.70k | 売り | 42.70 | 45.77k | -30.87% |
| 2026-01-13 | Mr. David L. HallalCEO & Chairman of the Board | -57.45k | 2.45M | 売り | 42.70 | 371.65k | -13.39% |
| 2025-12-16 | Ms. Katie PengIndependent Director | -1.01k | 44.35k | Automatic Disposition | 43.88 - 44.63 | 14.84k | -6.35% |
| 2025-10-07 | Samsara BioCapital LLC法人 | 4.40k | 180.39k | 買い | 40.97 | 6.37M | 0.07% |
| 2025-10-07 | Samsara BioCapital LLC法人 | 25.20k | 1.00M | 買い | 39.31 - 40.18 | 6.37M | 0.40% |
| 2025-12-12 | Samsara BioCapital LLC法人 | 1.06M | 7.83M | Derivative Exercise and Retained Stock | 7.35 | 6.37M | 20.08% |
| 2025-12-04 | Mr. Mo QatananiChief Scientific Officer | -136.46k | 3.28M | Derivative Exercise and Sale | 4.86 - 45.21 | 108.96k | - |
| 2025-10-08 | Mr. David L. HallalCEO & Chairman of the Board | -205.00k | 0.00 | Other Disposition | - | 304.10k | -40.27% |
| 2025-10-03 | Samsara BioCapital LLC法人 | 500.44k | 18.81M | 買い | 35.61 - 39.52 | 5.30M | 10.42% |
| 2025-09-22 | Mr. Mo QatananiChief Scientific Officer | -3.35k | 102.85k | Automatic Disposition | 30.67 | 108.96k | -2.99% |
| 2025-09-16 | Mr. Mo QatananiChief Scientific Officer | -3.18k | 106.53k | 売り | 33.52 | 112.32k | -2.75% |
| 2025-09-16 | Ms. Katie PengIndependent Director | -1.01k | 32.73k | Automatic Disposition | 32.48 - 33.20 | 13.69k | -6.85% |
| 2025-08-18 | Ms. Caryn ParlavecchioChief HR Officer | -2.18k | 67.88k | 売り | 31.17 | 66.22k | -3.18% |
| 2025-07-16 | Dr. Jeffrey S. FlierIndependent Director & Member of Scientific Advisory Board | -11.14k | 445.69k | Automatic Disposition | 40.02 | 16.44k | -40.39% |
| 2025-07-08 | Mr. Mo QatananiChief Scientific Officer | -24.07k | 828.90k | Automatic Disposition | 34.44 | 0.00 | -100.00% |
| 2025-06-23 | Dr. Jeffrey S. FlierIndependent Director & Member of Scientific Advisory Board | -20.32k | 215.67k | Derivative Exercise and Sale | 21.62 - 32.74 | 27.57k | - |
| 2025-06-23 | Dr. Jeffrey S. FlierIndependent Director & Member of Scientific Advisory Board | -11.14k | 369.82k | Automatic Disposition | 33.21 | 27.57k | -28.77% |
| 2025-06-16 | Ms. Junlin HoGeneral Counsel & Corporate Secretary | -7.44k | 238.15k | 売り | 32.00 | 105.65k | -6.58% |
| 2025-06-16 | Ms. Katie PengIndependent Director | -3.03k | 96.89k | Automatic Disposition | 31.96 - 32.53 | 12.39k | -19.66% |
| 2025-06-16 | Mr. Mo QatananiChief Scientific Officer | -3.67k | 117.38k | 売り | 32.00 | 24.07k | -13.23% |
| 2025-06-16 | Ms. Caryn ParlavecchioChief HR Officer | -6.19k | 197.96k | 売り | 32.00 | 64.20k | -8.79% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
